| Skeletal muscle as potential central link between sarcopenia and immune senescence C Nelke, R Dziewas, J Minnerup, SG Meuth, T Ruck EBioMedicine 49, 381-388, 2019 | 352 | 2019 |
| Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society N Melzer, T Ruck, P Fuhr, R Gold, R Hohlfeld, A Marx, A Melms, ... Journal of neurology 263, 1473-1494, 2016 | 314 | 2016 |
| Alemtuzumab in multiple sclerosis: mechanism of action and beyond T Ruck, S Bittner, H Wiendl, SG Meuth International journal of molecular sciences 16 (7), 16414-16439, 2015 | 251 | 2015 |
| Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS S Bittner, T Ruck, MK Schuhmann, AM Herrmann, HMO Maati, N Bobak, ... Nature medicine 19 (9), 1161-1165, 2013 | 165 | 2013 |
| Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation TFM Andlauer, D Buck, G Antony, A Bayas, L Bechmann, A Berthele, ... Science advances 2 (6), e1501678, 2016 | 157 | 2016 |
| Immune cell activation in the cerebrospinal fluid of patients with Parkinson's disease JB Schröder, M Pawlowski, G Meyer zu Hörste, CC Gross, H Wiendl, ... Frontiers in neurology 9, 1081, 2018 | 131 | 2018 |
| Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells K Göbel, S Pankratz, CM Asaridou, AM Herrmann, S Bittner, M Merker, ... Nature communications 7 (1), 11626, 2016 | 128 | 2016 |
| Cytokine signaling in multiple sclerosis: Lost in translation K Göbel, T Ruck, SG Meuth Multiple Sclerosis Journal 24 (4), 432-439, 2018 | 124 | 2018 |
| Isolation of primary murine brain microvascular endothelial cells T Ruck, S Bittner, L Epping, AM Herrmann, SG Meuth Journal of visualized experiments: JoVE, 52204, 2014 | 123 | 2014 |
| Understanding the burden of refractory myasthenia gravis C Schneider-Gold, T Hagenacker, N Melzer, T Ruck Therapeutic advances in neurological disorders 12, 1756286419832242, 2019 | 117 | 2019 |
| Advances in muscle health and nutrition: a toolkit for healthcare professionals CM Prado, F Landi, STH Chew, PJ Atherton, J Molinger, T Ruck, ... Clinical Nutrition 41 (10), 2244-2263, 2022 | 110 | 2022 |
| Immune reconstitution therapies: concepts for durable remission in multiple sclerosis JD Lünemann, T Ruck, PA Muraro, A Bar-Or, H Wiendl Nature Reviews Neurology 16 (1), 56-62, 2020 | 108 | 2020 |
| Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis NC Landmeyer, PC Buerkner, H Wiendl, T Ruck, HP Hartung, H Holling, ... Neurology 94 (22), e2373-e2383, 2020 | 105 | 2020 |
| Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis CC Gross, D Ahmetspahic, T Ruck, A Schulte-Mecklenbeck, K Schwarte, ... Neurology: Neuroimmunology & Neuroinflammation 3 (6), e289, 2016 | 105 | 2016 |
| Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans V Fleischer, G Gonzalez-Escamilla, D Ciolac, P Albrecht, P Küry, ... Proceedings of the National Academy of Sciences 118 (36), e2025000118, 2021 | 99 | 2021 |
| Skeletal muscle cells actively shape (auto) immune responses AM Afzali, T Müntefering, H Wiendl, SG Meuth, T Ruck Autoimmunity Reviews 17 (5), 518-529, 2018 | 94 | 2018 |
| Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double … B Schoser, M Roberts, BJ Byrne, S Sitaraman, H Jiang, P Laforêt, ... The Lancet Neurology 20 (12), 1027-1037, 2021 | 92 | 2021 |
| Ocrelizumab extended interval dosing in multiple sclerosis in times of COVID-19 L Rolfes, M Pawlitzki, S Pfeuffer, C Nelke, A Lux, R Pul, C Kleinschnitz, ... Neurology: Neuroimmunology & Neuroinflammation 8 (5), e1035, 2021 | 89 | 2021 |
| Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management S Bittner, T Ruck, H Wiendl, OM Grauer, SG Meuth Therapeutic advances in neurological disorders 10 (1), 51-66, 2017 | 87 | 2017 |
| The impact of dysphagia in myositis: a systematic review and meta-analysis B Labeit, M Pawlitzki, T Ruck, P Muhle, I Claus, S Suntrup-Krueger, ... Journal of clinical medicine 9 (7), 2150, 2020 | 72 | 2020 |
